Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene by S.M.C. Titah et al.
Cataract as a phenotypic marker for a mutation in WFS1, the
Wolfram syndrome gene
Submitted by Guy Lenaers on Tue, 04/07/2015 - 15:29
Titre Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene
Type de
publication Article de revue
Auteur
Titah, Salah Mohamed Cherif [1], Meunier, Isabelle [2], Blanchet, Catherine [3],
Lopez, Severine [4], Rondouin, Gerard [5], Lenaers, Guy [6], Amati-Bonneau, Patrizia












revue European Journal of Ophtalmology
ISSN 1724-6016
Mots-clés
Adult [11], Cataract [12], Cataract Extraction [13], DNA, Mitochondrial [14], Evoked
Potentials, Visual [15], Exons [16], Female [17], Genetic Markers [18], GTP
Phosphohydrolases [19], Heterozygote [20], Humans [21], Membrane Proteins [22],
Mutation [23], Pedigree [24], Phenotype [25], proteins [26], Visual Acuity [27], Visual
Fields [28], Wolfram Syndrome [29], Young Adult [30]
Résumé en
anglais
PURPOSE: Wolfram syndrome (WS) or diabetes insipidus, diabetes mellitus, optic
atrophy, and deafness (DIDMOAD) (OMIM 222300) is an inherited neurodegenerative
disease characterized by diabetes mellitus and optic atrophy as the 2 major criteria,
followed later in life by deafness, diabetes insipidus, and various signs of neurologic
impairment. The presence of a cataract has been variably mentioned in WS.
METHOD: Two members of a family had thorough ophthalmic examination and their
DNA was screened for mutations in mitochondrial DNA, WFS1, OPA1, and OPA3
genes.
RESULTS: We report a patient who first had surgery for bilateral cataract at age 5
and who subsequently presented typical signs of WS, i.e., diabetes mellitus, optic
atrophy with reduced visual acuity at 20/400 on both eyes at age 22, and mild
deafness. The patient was found to be a compound heterozygote for 2 truncating
mutations in WFS1, the major WS gene. She carried the previously reported
c.1231_1233 delCT and a novel c.2431_2465dup35 mutation. She also was
heterozygote for a novel OPA1 sequence variant, c.929A>G in exon 9, whose
pathogenicity remains uncertain. The patient's mother was a heterozygous carrier of
the c.2431_2465dup35 mutation. She did not have diabetes mellitus or optic atrophy
but had bilateral polar cataract. She did not carry the OPA1 sequence variant.
CONCLUSIONS: Cataract could be a marker for the WFS1 heterozygosity in this
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